DE69800895D1 - Interleukin-1 Rezeptor Antagonist beta (il-1rabeta) - Google Patents

Interleukin-1 Rezeptor Antagonist beta (il-1rabeta)

Info

Publication number
DE69800895D1
DE69800895D1 DE69800895T DE69800895T DE69800895D1 DE 69800895 D1 DE69800895 D1 DE 69800895D1 DE 69800895 T DE69800895 T DE 69800895T DE 69800895 T DE69800895 T DE 69800895T DE 69800895 D1 DE69800895 D1 DE 69800895D1
Authority
DE
Germany
Prior art keywords
1rabeta
interleukin
receptor antagonist
antagonist beta
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69800895T
Other languages
English (en)
Inventor
Peter R Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE69800895D1 publication Critical patent/DE69800895D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69800895T 1997-01-28 1998-01-27 Interleukin-1 Rezeptor Antagonist beta (il-1rabeta) Expired - Lifetime DE69800895D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/790,032 US5863769A (en) 1997-01-28 1997-01-28 DNA encoding interleukin-1 receptor antagonist (IL-1raβ)
CA002232812A CA2232812A1 (en) 1997-01-28 1998-03-20 Interleukin-1 receptor antagonist beta (il-1ra.beta.)

Publications (1)

Publication Number Publication Date
DE69800895D1 true DE69800895D1 (de) 2001-07-19

Family

ID=31979142

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69800895T Expired - Lifetime DE69800895D1 (de) 1997-01-28 1998-01-27 Interleukin-1 Rezeptor Antagonist beta (il-1rabeta)

Country Status (5)

Country Link
US (1) US5863769A (de)
EP (1) EP0855404B1 (de)
JP (2) JPH10304888A (de)
CA (1) CA2232812A1 (de)
DE (1) DE69800895D1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054559A (en) 1997-01-28 2000-04-25 Smithkline Beecham Corporation Interleukin-1 receptor antagonist beta (IL-1raβ)
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US6197551B1 (en) 1998-01-27 2001-03-06 Millennium Pharmaceuticals, Inc. Spoil-1 protein and nucleic acid molecules and uses therefor
US20030082688A1 (en) * 1998-01-27 2003-05-01 Millennium Pharmaceuticals, Inc. Spoil protein and nucleic acid molecules and uses therefor
US6541623B1 (en) * 1998-04-03 2003-04-01 Hyseq, Inc. Interleukin—1 receptor antagonist and uses thereof
NZ510497A (en) * 1998-08-21 2003-09-26 Immunex Corp Human IL-1 epsilon DNA and polypeptides
US6949359B1 (en) 1998-08-21 2005-09-27 Immunex Corporation Human IL-1 epsilon DNA and polypeptides
US6838290B2 (en) 1998-08-21 2005-01-04 Immunex Corporation Methods for screening compounds that affect IL-1 epsilon activity
US6680380B1 (en) 1998-09-18 2004-01-20 Schering Corporation Nucleic acids encoding mammalian interleukin-1ζ, related reagents and methods
IL126562A0 (en) * 1998-10-14 1999-08-17 Interpharm Lab Ltd Expression and secretion of icil-1 receptor antagonist type ii
EP2319929A1 (de) 1998-12-23 2011-05-11 Genentech, Inc. Mit IL-1 in Zusammenhang stehende Polypeptide
US20030007972A1 (en) * 1999-02-24 2003-01-09 Edward Tobinick Cytokine antagonists and other biologics for the treatment of bone metastases
US6471961B1 (en) * 1999-02-24 2002-10-29 Edward L. Tobinick Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
US7214658B2 (en) * 2004-07-06 2007-05-08 Tact Ip, Llc Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection
US6423321B2 (en) 1999-02-24 2002-07-23 Edward L. Tobinick Cytokine antagonists for the treatment of sensorineural hearing loss
US6982089B2 (en) 1999-02-24 2006-01-03 Tact Ip, Llc Cytokine antagonists for neurological and neuropsychiatric disorders
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
CA2381284A1 (en) 1999-08-04 2001-02-15 Amgen Inc. Fhm, a novel member of the tnf ligand supergene family
WO2001010908A1 (en) 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
JP2003516132A (ja) * 1999-12-10 2003-05-13 アムジェン インコーポレイテッド インターロイキン−１レセプターアンタゴニスト様分子およびその使用
CA2395417A1 (en) * 1999-12-10 2001-06-14 Amgen Inc. Interleukin-1 receptor antagonist-related molecules and uses thereof
WO2001057219A2 (en) * 2000-02-02 2001-08-09 Schering Corporation Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
US6623736B2 (en) * 2000-05-02 2003-09-23 Edward L. Tobinick Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
US7087224B2 (en) * 2000-10-31 2006-08-08 Amgen Inc. Method of treating anemia by administering IL-1ra
CA2499843A1 (en) * 2002-09-25 2004-04-08 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis
JP2006517191A (ja) 2002-12-30 2006-07-20 アムジエン・インコーポレーテツド 共刺激因子を用いた併用療法
GB0607189D0 (en) * 2006-04-10 2006-05-17 Polybiomed Ltd interleukin IL 1ra composition
DK2068889T3 (da) * 2006-08-10 2020-02-03 Roy C Levitt Anakinra til anvendelse i behandling af bronchiolitis obliterans syndrom
US7947283B2 (en) * 2007-08-30 2011-05-24 Wyntek Corporation Compositions and methods for treating psoriasis by Ganoderma lucidum (Reishi) polysaccharides
US8323635B2 (en) 2007-11-14 2012-12-04 General Regeneratives, Ltd. Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
US20160000936A1 (en) 2014-06-10 2016-01-07 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
PE20211295A1 (es) 2018-12-21 2021-07-20 23Andme Inc Anticuerpos anti il-36 y procedimientos de uso de estos
CN112979781B (zh) * 2021-03-18 2022-05-17 中国海洋大学 一种许氏平鲉IL-1β重组蛋白及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1269989B (it) * 1994-09-21 1997-04-16 Dompe Spa Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria

Also Published As

Publication number Publication date
US5863769A (en) 1999-01-26
CA2232812A1 (en) 1999-09-20
JPH10304888A (ja) 1998-11-17
JP2000032990A (ja) 2000-02-02
EP0855404A1 (de) 1998-07-29
EP0855404B1 (de) 2001-06-13

Similar Documents

Publication Publication Date Title
DE69800895D1 (de) Interleukin-1 Rezeptor Antagonist beta (il-1rabeta)
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
IS5706A (is) Adenosín A3 viðtakastillar
DE69812096T2 (de) Neuropeptid y rezeptorantagonisten
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DE69926861D1 (de) Beta 2- adrenergische rezeptoragonisten
ATE315035T1 (de) Ccr-3-rezeptor-antagonisten
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69921351D1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
EP1047782A4 (de) INTERLEUKIN-1 REZEPTOR ANTAGONIST BETA IL-1 ra
NO993350D0 (no) Vitronectin-reseptor-antagonister
ID24726A (id) Antagonis-antagonis reseptor trombin
NO20001514D0 (no) Vitronectin-reseptor-antagonist
ID24162A (id) Antagonis-antagonis reseptor vitronektin
NO20001515D0 (no) Vitronektin reseptor-antagonist
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
BR9507220A (pt) Antagonistas de receptores de endotelina
ID26086A (id) Ligan-ligan reseptor 5ht1 azabisiklik
ATE381330T1 (de) Il-8 rezeptor-antagonisten
TR199501389A2 (tr) Adesyon reseptörü antagonistleri (karsitlari).
DK1146874T3 (da) Vitronectinreceptoragonist
ATE303370T1 (de) Il-8 rezeptor antagonisten
DE69830445D1 (de) Beta-Chinacridonpigment
DE69824837D1 (de) Il-8-rezeptor-antagonisten
BR9510060A (pt) Receptor

Legal Events

Date Code Title Description
8332 No legal effect for de